Report

Global Upstream Bioprocessing Market Size study, by Product, by Usage Mode, by Mode, by Application, by End-user and Regional Forecasts 2022-2032

  • Publish Date: Sep,2024
  • Report ID: 3-1-1869
  • Page : 200
  • Report Type : PDF (Email)
Table of Contents
Chapter 1. Global Upstream Bioprocessing Market Executive Summary
1.1. Global Upstream Bioprocessing Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Usage Mode
1.3.3. By Mode
1.3.4. By Application
1.3.5. By End-user
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Upstream Bioprocessing Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Upstream Bioprocessing Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Adoption of Single-use Bioprocessing Systems
3.1.2. Rising Implementation of Process Analytical Technology (PAT)
3.1.3. Increasing Demand for Biopharmaceuticals
3.2. Market Challenges
3.2.1. Technical and Operational Challenges Related to Upstream Bioprocessing
3.2.2. High Capital Costs
3.3. Market Opportunities
3.3.1. Growing Investment in R&D
3.3.2. Development of Innovative Solutions
3.3.3. Collaboration and Partnerships for Increasing Awareness and Education
Chapter 4. Global Upstream Bioprocessing Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Upstream Bioprocessing Market Size & Forecasts by Product 2022-2032
5.1. Segment Dashboard
5.2. Global Upstream Bioprocessing Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Bioreactors/Fermenters
5.2.2. Cell culture products
5.2.3. Filters
5.2.4. Bioreactor accessories
5.2.5. Bags & containers
5.2.6. Other products
Chapter 6. Global Upstream Bioprocessing Market Size & Forecasts by Usage Mode 2022-2032
6.1. Segment Dashboard
6.2. Global Upstream Bioprocessing Market: Usage Mode Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Multi-use
6.2.2. Single-use
Chapter 7. Global Upstream Bioprocessing Market Size & Forecasts by Mode 2022-2032
7.1. Segment Dashboard
7.2. Global Upstream Bioprocessing Market: Mode Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. In-house
7.2.2. Outsourced
Chapter 8. Global Upstream Bioprocessing Market Size & Forecasts by Application 2022-2032
8.1. Segment Dashboard
8.2. Global Upstream Bioprocessing Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Monoclonal antibody production
8.2.2. Vaccine production
8.2.3. Cell and gene therapy production
8.2.4. Other applications
Chapter 9. Global Upstream Bioprocessing Market Size & Forecasts by End-user 2022-2032
9.1. Segment Dashboard
9.2. Global Upstream Bioprocessing Market: End-user Revenue Trend Analysis, 2022 & 2032 (USD Billion)
9.2.1. Biopharmaceutical companies
9.2.2. CDMOs and CROs
9.2.3. Research and academic institutes
Chapter 10. Global Upstream Bioprocessing Market Size & Forecasts by Region 2022-2032
10.1. North America Upstream Bioprocessing Market
10.1.1. U.S. Upstream Bioprocessing Market
10.1.1.1. Product breakdown size & forecasts, 2022-2032
10.1.1.2. Usage Mode breakdown size & forecasts, 2022-2032
10.1.1.3. Mode breakdown size & forecasts, 2022-2032
10.1.1.4. Application breakdown size & forecasts, 2022-2032
10.1.1.5. End-user breakdown size & forecasts, 2022-2032
10.1.2. Canada Upstream Bioprocessing Market
10.1.2.1. Product breakdown size & forecasts, 2022-2032
10.1.2.2. Usage Mode breakdown size & forecasts, 2022-2032
10.1.2.3. Mode breakdown size & forecasts, 2022-2032
10.1.2.4. Application breakdown size & forecasts, 2022-2032
10.1.2.5. End-user breakdown size & forecasts, 2022-2032
10.2. Europe Upstream Bioprocessing Market
10.2.1. U.K. Upstream Bioprocessing Market
10.2.2. Germany Upstream Bioprocessing Market
10.2.3. France Upstream Bioprocessing Market
10.2.4. Spain Upstream Bioprocessing Market
10.2.5. Italy Upstream Bioprocessing Market
10.2.6. Rest of Europe Upstream Bioprocessing Market
10.3. Asia-Pacific Upstream Bioprocessing Market
10.3.1. China Upstream Bioprocessing Market
10.3.2. India Upstream Bioprocessing Market
10.3.3. Japan Upstream Bioprocessing Market
10.3.4. Australia Upstream Bioprocessing Market
10.3.5. South Korea Upstream Bioprocessing Market
10.3.6. Rest of Asia Pacific Upstream Bioprocessing Market
10.4. Latin America Upstream Bioprocessing Market
10.4.1. Brazil Upstream Bioprocessing Market
10.4.2. Mexico Upstream Bioprocessing Market
10.4.3. Rest of Latin America Upstream Bioprocessing Market
10.5. Middle East & Africa Upstream Bioprocessing Market
10.5.1. Saudi Arabia Upstream Bioprocessing Market
10.5.2. South Africa Upstream Bioprocessing Market
10.5.3. Rest of Middle East & Africa Upstream Bioprocessing Market
Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Corning, Inc.
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Market Strategies
11.3.2. Danaher Corporation (Cytvia)
11.3.3. Eppendorf AG
11.3.4. Merck KGaA
11.3.5. PBS Biotech, Inc.
11.3.6. Sartorius AG
11.3.7. Thermo Fisher Scientific Inc.
11.3.8. Applikon Biotechnology
11.3.9. Boehringer Ingelheim GmbH
11.3.10. CellGenix GmbH
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes